ANGUS reveals ANGUS Life Sciences as a new company division that will serve pharmaceutical, biotechnology, and agriculture markets.
ANGUS Chemical Company, a manufacturer and marketer of nitroalkanes and their derivatives, announced on March 14, 2016 the launch of its new life-sciences division, ANGUS Life Sciences. ANGUS Life Sciences supplies customers in the biotechnology, pharmaceutical, and agriculture markets with buffers, biochemicals, biomolecules, and intermediates.
Based in the US, ANGUS Life Sciences is a fully integrated manufacturer of TRIS AMINO buffers, based on their nitroalkane chemistry. In addition to TRIS AMINO, ANGUS Life Sciences also provides other offerings, including biological buffers, biochemicals, biomolecules, and amino acids.
Source: ANGUS
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.